Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer

Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer

Being the fourth most fatal malignancy worldwide, pancreatic cancer is on track to become the second leading cause of cancer-related deaths in the United States by 2030. Gemcitabine is a first-line chemotherapeutic agent for pancreatic ductal adenocarcinoma (PDAC). Gemcitabine Elaidate (Gem Elaidate...

Full description

Bibliographic Details
Main Authors: Akanksha Patel, Aishwarya Saraswat, Harsh Patel, Zhe-Sheng Chen, Ketan Patel
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
Gemcitabine Elaidate
Protein kinase C
Palmitoyl-DL-carnitine chloride
pancreatic cancer
Online Access:https://www.mdpi.com/2072-6694/15/1/182

Internet

https://www.mdpi.com/2072-6694/15/1/182

Similar Items